Highly Active Antiretroviral Therapy-Associated Ptosis in Patients With Human Immunodeficiency Virus

被引：5
|
作者：
Silkiss, Rona Z. [1 ]
Lee, Han [1 ]
Ray, Vincent L. Gills [1 ]
机构：
[1] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA 94115 USA
来源：
ARCHIVES OF OPHTHALMOLOGY | 2009年 / 127卷 / 03期
关键词：
IMMUNE-DEFICIENCY-SYNDROME; MYOPATHY;
D O I：
10.1001/archophthalmol.2009.11
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：345 / 346
页数：3
相关论文
共 50 条
  • [21] Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy
    Josep Lloreta
    Pere Domingo
    Ramón M. Pujol
    Juan A. Arroyo
    Núria Baixeras
    Xavier Matias-Guiu
    Montserrat Gilaberte
    Maria A. Sambeat
    Sergi Serrano
    [J]. Virchows Archiv, 2002, 441 : 599 - 604
  • [22] The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy
    Sacktor, N
    [J]. JOURNAL OF NEUROVIROLOGY, 2002, 8 : 115 - 121
  • [23] The natural history of human immunodeficiency virus-associated nephropathy in the era of highly active antiretroviral therapy
    Lee, W
    Klotman, P
    Klotman, M
    Winston, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 39A - 39A
  • [24] Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia
    Gendelman, HE
    Zheng, JL
    Coulter, CL
    Ghorpade, A
    Che, M
    Thylin, M
    Rubocki, R
    Persidsky, Y
    Hahn, F
    Reinhard, J
    Swindells, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04): : 1000 - 1007
  • [25] Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy
    Torre, D
    Tambini, R
    Cadario, F
    Barbarini, G
    Moroni, M
    Basilico, C
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) : 1579 - 1585
  • [26] Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection
    Aranzabal, L
    Casado, JL
    Moya, J
    Quereda, C
    Diz, S
    Moreno, A
    Moreno, L
    Antela, A
    Perez-Elías, MJ
    Dronda, F
    Marín, A
    Hernandez-Ranz, F
    Moreno, A
    Moreno, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (04) : 588 - 593
  • [27] Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy
    Camino, X
    Iribarren, JA
    Arrizabalaga, J
    Rodríguez, F
    von Wichmann, MA
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (02): : 85 - 86
  • [28] Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients
    Duro, M.
    Rebelo, I.
    Barreira, S.
    Sarmento-Castro, R.
    Medeiros, R.
    Almeida, C.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (11) : 796 - 802
  • [29] Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy
    Shekatkar, Madhura
    Kheur, Supriya
    Gupta, Archana A.
    Arora, Aavishi
    Raj, A. Thirumal
    Patil, Shankargouda
    Khan, Samar Saeed
    Desai, Ami
    Carroll, William B.
    Awan, Kamran Habib
    [J]. DM DISEASE-A-MONTH, 2021, 67 (09):
  • [30] Association of Highly Active Antiretroviral Therapy With Increased Arterial Stiffness in Patients Infected With Human Immunodeficiency Virus
    Lekakis, John
    Ikonomidis, Ignatios
    Palios, John
    Tsiodras, Sotirios
    Karatzis, Emmanouil
    Poulakou, Garyfalia
    Rallidis, Loukianos
    Antoniadou, Anastasia
    Panagopoulos, Periklis
    Papadopoulos, Antonios
    Triantafyllidi, Helen
    Giamarellou, Helen
    Kremastinos, Dimitrios T.
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (08) : 828 - 834
12345